ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.130
-0.070 (-5.83%)
At close: Apr 10, 2025, 4:00 PM
1.189
+0.059 (5.22%)
After-hours: Apr 10, 2025, 7:47 PM EDT

ProQR Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
119273161264570211
Upgrade
Market Cap Growth
70.19%70.19%-39.20%-53.63%170.61%-55.73%
Upgrade
Enterprise Value
-1819356187430145
Upgrade
Last Close Price
1.132.651.983.708.014.20
Upgrade
PS Ratio
4.8113.5222.0556.74210.75167.33
Upgrade
PB Ratio
1.302.983.513.714.433.05
Upgrade
P/TBV Ratio
1.302.983.513.694.403.02
Upgrade
P/FCF Ratio
-7.21---
Upgrade
P/OCF Ratio
-6.75---
Upgrade
EV/Sales Ratio
9.559.557.6340.19158.93115.23
Upgrade
EV/FCF Ratio
-2.49---
Upgrade
Debt / Equity Ratio
0.190.190.480.330.530.61
Upgrade
Debt / FCF Ratio
--0.98---
Upgrade
Asset Turnover
0.130.130.040.020.020.01
Upgrade
Quick Ratio
3.893.893.517.246.837.44
Upgrade
Current Ratio
3.963.963.547.366.947.77
Upgrade
Return on Equity (ROE)
-42.73%-42.73%-51.33%-71.37%-71.62%-61.99%
Upgrade
Return on Assets (ROA)
-12.45%-12.45%-14.06%-21.38%-23.20%-29.36%
Upgrade
Return on Capital (ROIC)
-22.82%-22.82%-29.04%-31.06%-27.05%-32.03%
Upgrade
Earnings Yield
-24.18%-10.51%-19.34%-26.05%-12.12%-27.05%
Upgrade
FCF Yield
-35.80%-14.31%13.88%-27.99%-5.29%-27.87%
Upgrade
Buyback Yield / Dilution
-6.26%-6.26%-13.08%-11.62%-28.21%-21.99%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q